Nakhia Impex LLC: Clinical Trials

16 trials sponsored by Nakhia Impex LLC, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

16 completed. 16 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable16Completed 16

Follow Nakhia Impex LLC: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of HA35 Gel for Ultra-Rapid Skin Pruritus Relief
10% High-Concentration 35 kDa Hyaluronan (HA35) Topical Anti-Pruritic Gel - Skin Pruritus, Itch
Not applicableCompletedNakhia Impex LLC302026-06-202026-09-22
Efficacy of Oral HA35 for Rapid Relief of Oral Pain and Pungent Sensation
Capsaicin Oral Challenge, Allyl Isothiocyanate (AITC) Oral Challenge, 10% 35 kDa Hyaluronan (HA35) Oral Solution - Oral Pain, Oral Pungent Sensation
Not applicableCompletedNakhia Impex LLC302026-06-052026-09-10
Efficacy and Safety of HA35 Gel for Post-Dental Gingival Pain and Swelling
10% High-Concentration 35 kDa Hyaluronan (HA35) Oral Topical Gel - Post-Dental Gingival Pain, Gingival Swelling
Not applicableCompletedNakhia Impex LLC302026-06-012026-09-22
Efficacy and Safety of HA35 Gel for Mild Gingival Recession and Periodontal Inflammation
10% High-Concentration 35 kDa Hyaluronan (HA35) Gingival Topical Gel - Mild Gingival Recession, Periodontal Inflammation
Not applicableCompletedNakhia Impex LLC302026-06-012026-09-23
Efficacy and Safety of High-Dose Oral 35 kDa Hyaluronan for Aesthetic Improvement
High-Dose Oral 35 kDa Hyaluronan (HA35) - Facial Subcutaneous Fullness, Subcutaneous Fat Accumulation
Not applicableCompletedNakhia Impex LLC302026-05-202026-09-23
Efficacy and Safety of HA35 Gel Nighttime Occlusive Application for TMD Pain
10% High-Concentration 35 kDa Hyaluronan (HA35) Topical Gel - Temporomandibular Joint Disorders, TMD
Not applicableCompletedNakhia Impex LLC302026-05-202026-09-22
Efficacy and Safety of High-Concentration 35 kDa Hyaluronan Gel for Herpes Zoster-Associated Pain
10% High-Concentration 35 kDa Hyaluronan (HA35) Topical Analgesic Gel - Herpes Zoster, Zoster-Associated Pain
Not applicableCompletedNakhia Impex LLC302026-05-012026-09-23
Efficacy and Safety of Overnight Occlusive HA35 Gel for Facial Aesthetic Improvement
10% High-Concentration 35 kDa Hyaluronan (HA35) Facial Occlusive Gel - Facial Subcutaneous Fat, Facial Erythema
Not applicableCompletedNakhia Impex LLC302026-05-012026-09-23
Efficacy and Safety of High-Concentration 35 kDa Hyaluronan Gel for Chronic Nasopharyngitis
13.6% High-Concentration 35 kDa Hyaluronan (HA35) Nasopharyngeal Care Gel - Chronic Rhinitis, Chronic Pharyngitis
Not applicableCompletedNakhia Impex LLC302026-05-012026-09-23
Extended Therapeutic Effect of 35kDa Hyaluronan Fragment Injection in Patients With Chronic Pain Caused by Myofascial Pain Syndrome
HA35 injection - Chronic Wound, Myofascial Pain Syndrome
Not applicableCompletedNakhia Impex LLC102024-05-302026-09-22
35 kDa Hyaluronan Fragment (HA35) Reduces Chronic Inflammation of Skin
35 kDa hyaluronan fragment HA35 injection - Skin Inflammation, Cosmetic Skin
Not applicableCompletedNakhia Impex LLC202024-04-152026-09-23
35kDa Hyaluronan Fragment Treatment of Colorectal and Rectal Cancer
HA35 - Cancer Pain
Not applicableCompletedNakhia Impex LLC102023-12-202024-04-17
A Clinical Study of Pain and Discomfort Associated With Advanced Lung Cancer
35 kDa hyaluronan fragment - Advanced Lung Cancer
Not applicableCompletedNakhia Impex LLC102023-04-112024-01-17
Local Injection for the Treatment of Chronic Wounds and Pain Caused by Chronic Wounds
Freshly manufactured 35 kDa hyaluronan fragment - Pain, Chronic Wound
Not applicableCompletedNakhia Impex LLC242023-04-022024-04-17
Freshly Manufactured 35kDa Hyaluronan Fragment HA35 for the Treatment of Chronic Wounds
HA35(L20200708MP07707, Ministry of Health, Mongolia)was freshly manufactured by mixing hyaluronidase PH20 injectable solution (H31022111) and high-molecular-weight HA injectable solution (H20174089) - Chronic Wounds
Not applicableCompletedNakhia Impex LLC202020-07-062023-03-10
A Clinical Study of Freshly Manufactured 35kDa Hyaluronan Fragment in the Treatment of Pain
HA35(L20200708MP07707, Ministry of Health, Mongolia) was freshly manufactured by mixing hyaluronidase PH20 injectable solution (H31022111) and high-molecular-weight HA injectable solution (H20174089) - Shoulder Pain, Neck Pain
Not applicableCompletedDove Medical Press Ltd362020-07-062023-03-06

Conditions studied

Agnosia (3)  ·  Pain (3)  ·  Acute Pain (1)  ·  Back Pain (1)  ·  Body Weight (1)  ·  Bruxism (1)  ·  Cancer Pain (1)  ·  Colorectal Neoplasms (1)  ·  Cough (1)  ·  Dermatitis (1)  ·  Erythema (1)  ·  Fatigue (1)  ·  Gingival Hemorrhage (1)  ·  Gingival Recession (1)  ·  Herpes Zoster (1)

Interventions

2,3,4-tri-O-acetylarabinopyranosyl isothiocyanate (1)  ·  Fullerenes (1)  ·  Saline Solution (1)  ·  Solutions (1)  ·  allyl isothiocyanate (1)

Countries

China (13)  ·  Mongolia (3)

Results publications

PMID 36686276